Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8993 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1613 |
Approved |
0.8742 |
High Similarity |
NPD7074 |
Phase 3 |
0.8705 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8643 |
High Similarity |
NPD3027 |
Phase 3 |
0.8633 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD7054 |
Approved |
0.8543 |
High Similarity |
NPD1653 |
Approved |
0.8509 |
High Similarity |
NPD7472 |
Approved |
0.8457 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8405 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8367 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8201 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8182 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.816 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8113 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1934 |
Approved |
0.795 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7925 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD37 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7812 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7751 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7751 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7584 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7439 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7434 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7375 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7361 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7337 |
Intermediate Similarity |
NPD7680 |
Approved |
0.731 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD228 |
Approved |
0.7262 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8313 |
Approved |
0.725 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7234 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7229 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7211 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7203 |
Intermediate Similarity |
NPD7157 |
Approved |
0.72 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7183 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7175 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD290 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7048 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7021 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7021 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5401 |
Approved |
0.6994 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6981 |
Remote Similarity |
NPD5763 |
Approved |
0.6981 |
Remote Similarity |
NPD5762 |
Approved |
0.6981 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6974 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6962 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6961 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5126 |
Approved |
0.6959 |
Remote Similarity |
NPD5846 |
Approved |
0.6959 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6951 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD7095 |
Approved |
0.6937 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6799 |
Approved |
0.6928 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6927 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD2796 |
Approved |
0.6906 |
Remote Similarity |
NPD7906 |
Approved |
0.6897 |
Remote Similarity |
NPD2489 |
Approved |
0.6897 |
Remote Similarity |
NPD27 |
Approved |
0.6897 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD3060 |
Approved |
0.6891 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.689 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD5735 |
Approved |
0.6875 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6875 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6872 |
Remote Similarity |
NPD7310 |
Approved |
0.6872 |
Remote Similarity |
NPD7312 |
Approved |
0.6872 |
Remote Similarity |
NPD7313 |
Approved |
0.6872 |
Remote Similarity |
NPD7311 |
Approved |
0.6855 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD7466 |
Approved |
0.6852 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6851 |
Remote Similarity |
NPD4663 |
Approved |
0.6839 |
Remote Similarity |
NPD2970 |
Approved |
0.6839 |
Remote Similarity |
NPD2969 |
Approved |
0.6833 |
Remote Similarity |
NPD7309 |
Approved |
0.6829 |
Remote Similarity |
NPD1774 |
Approved |
0.6826 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6821
|
Remote Similarity |
NPD8127 |
Discontinued |